Загрузка...
Immune-based therapies in acute leukemia
Treatment resistance remains a leading cause of acute leukemia -related deaths. Thus, there is an unmet need to develop novel approaches to improve outcome. New immune-based therapies with chimeric antigen receptor (CAR) T cells, bi-specific T cell engagers (BiTEs) and immune checkpoint blockers (IC...
Сохранить в:
| Опубликовано в: : | Trends Cancer |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859901/ https://ncbi.nlm.nih.gov/pubmed/31706508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2019.07.009 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|